-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $17

Benzinga·11/18/2026 12:05:45
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $16 to $17.